Moneycontrol
Last Updated : Nov 09, 2018 09:42 AM IST | Source: Moneycontrol.com

Biocon opens higher as Citi maintains buy rating

Citi added that Biocon is one of its top picks. Risk-reward ratio is favourable at current levels

Moneycontrol News @moneycontrolcom
Representative image
Representative image

Shares of Biocon climbed over 1 percent in early trade after Citi retained its buy rating on the stock with a target price of Rs 800 per share.

The biosimilars business is at an inflection point, the financial service company said in its research note.

Citi added that Biocon is one of its top picks. Risk-reward ratio is favourable at current levels.

At 09:26 hours, Biocon was quoting at Rs 639.40 on BSE, up 1.03 percent.
First Published on Nov 9, 2018 09:41 am
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant